A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?
Authors
Keywords
-
Journal
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
Volume 372, Issue 1721, Pages 20160295
Publisher
The Royal Society
Online
2017-04-11
DOI
10.1098/rstb.2016.0295
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chimpanzee Adenovirus Vector Ebola Vaccine
- (2017) Julie E. Ledgerwood et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
- (2017) Jason A. Regules et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection
- (2016) Andrew I. Flyak et al. CELL
- Ebola Viral Glycoprotein Bound to Its Endosomal Receptor Niemann-Pick C1
- (2016) Han Wang et al. CELL
- Inhibitory Antibodies Targeting Emerging Viruses: Advancements and Mechanisms
- (2016) Jing Jin et al. Clinical and Vaccine Immunology
- Viral vectors as vaccine platforms: from immunogenicity to impact
- (2016) Katie J Ewer et al. CURRENT OPINION IN IMMUNOLOGY
- Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines
- (2016) Iain D. Milligan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial
- (2016) Milagritos D Tapia et al. LANCET INFECTIOUS DISEASES
- Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study
- (2016) Olga De Santis et al. LANCET INFECTIOUS DISEASES
- A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA
- (2016) Katie Ewer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment
- (2016) David K. Clarke et al. VACCINE
- Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever
- (2016) George M. Warimwe et al. Scientific Reports
- Structural Basis for Marburg Virus Neutralization by a Cross-Reactive Human Antibody
- (2015) Takao Hashiguchi et al. CELL
- Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress
- (2015) Julie M. Fox et al. CELL
- A PfRH5-Based Vaccine Is Efficacious against Heterologous Strain Blood-Stage Plasmodium falciparum Infection in Aotus Monkeys
- (2015) Alexander D. Douglas et al. Cell Host & Microbe
- Recombinant modified vaccinia virus Ankara-based malaria vaccines
- (2015) Sarah Sebastian et al. Expert Review of Vaccines
- Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies
- (2015) Edgar Davidson et al. JOURNAL OF VIROLOGY
- Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial
- (2015) Hannah Kibuuka et al. LANCET
- Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial
- (2015) Feng-Cai Zhu et al. LANCET
- Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
- (2015) Ana Maria Henao-Restrepo et al. LANCET
- The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
- (2015) Angela Huttner et al. LANCET INFECTIOUS DISEASES
- Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases
- (2015) Claire M Tully et al. LANCET INFECTIOUS DISEASES
- Human Ebola virus infection results in substantial immune activation
- (2015) Anita K. McElroy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunology of protection from Ebola virus infection
- (2015) Philip R. Krause et al. Science Translational Medicine
- Progress with viral vectored malaria vaccines: A multi-stage approach involving “unnatural immunity”
- (2015) Katie J. Ewer et al. VACCINE
- Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial
- (2015) E. T. Overton et al. Open Forum Infectious Diseases
- First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)
- (2015) Jonathan D. Fuchs et al. Open Forum Infectious Diseases
- Camouflage and Misdirection: The Full-On Assault of Ebola Virus Disease
- (2014) John Misasi et al. CELL
- Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical Trial
- (2014) U. N. Sarwar et al. JOURNAL OF INFECTIOUS DISEASES
- Lyophilisation of influenza, rabies and Marburg lentiviral pseudotype viruses for the development and distribution of a neutralisation -assay-based diagnostic kit
- (2014) Stuart T. Mather et al. JOURNAL OF VIROLOGICAL METHODS
- Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study
- (2014) Glenda E Gray et al. LANCET INFECTIOUS DISEASES
- Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge
- (2014) Daphne A Stanley et al. NATURE MEDICINE
- Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals
- (2014) Haitao Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Which Antibody Functions are Important for an HIV Vaccine?
- (2014) Bin Su et al. Frontiers in Immunology
- Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA
- (2013) Jens H. Kuhn et al. ARCHIVES OF VIROLOGY
- Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine
- (2011) Nicole Frahm et al. JOURNAL OF CLINICAL INVESTIGATION
- Management of Accidental Exposure to Ebola Virus in the Biosafety Level 4 Laboratory, Hamburg, Germany
- (2011) Stephan Günther et al. JOURNAL OF INFECTIOUS DISEASES
- Recombinant Vesicular Stomatitis Virus–Based Vaccines Against Ebola and Marburg Virus Infections
- (2011) Thomas W. Geisbert et al. JOURNAL OF INFECTIOUS DISEASES
- Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge
- (2011) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates
- (2011) Nancy J Sullivan et al. NATURE MEDICINE
- High Prevalence of Both Humoral and Cellular Immunity to Zaire ebolavirus among Rural Populations in Gabon
- (2010) Pierre Becquart et al. PLoS One
- A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults
- (2010) J.E. Ledgerwood et al. VACCINE
- Human Fatal Zaire Ebola Virus Infection Is Associated with an Aberrant Innate Immunity and with Massive Lymphocyte Apoptosis
- (2010) Nadia Wauquier et al. PLoS Neglected Tropical Diseases
- Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus
- (2009) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule
- (2009) Nancy J. Sullivan et al. NATURE REVIEWS MICROBIOLOGY
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
- (2008) Susan P Buchbinder et al. LANCET
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started